VLKIM
OGN icon

Van Lanschot Kempen Investment Management’s Organon & Co OGN Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-346
Closed -$11K – 213
2021
Q4 		$11K Hold
346
– – ﹤0.01% 191
2021
Q3 		$11K Hold
346
– – ﹤0.01% 205
2021
Q2 		$10K Buy
+346
New +$11.4K ﹤0.01% 201

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Van Lanschot Kempen Investment Management's OGN Position: Q1 2022 in Review

Van Lanschot Kempen Investment Management sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 346 shares — an estimated $11K sold.

Van Lanschot Kempen Investment Management first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $11K in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Van Lanschot Kempen Investment Management reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 346 Organon & Co shares in Q1 2022, an estimated $11K.
  • Van Lanschot Kempen Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Van Lanschot Kempen Investment Management's Organon & Co position peaked at $11K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2022, filed 13 May 2022.